Skip to main content

Table 4 Cost differences between treatment arms

From: Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial

 

Mean, £

95% CI

Unadjusted analysis

 LSVT vs NHS SLT* (n = 48)

1256

(601, 1946)

 NHS SLT vs control* (n = 52)

294

(− 149, 727)

 LSVT vs control* (n = 52)

1550

(944, 2217)

Controlling for duration of illness

 LSVT vs NHS SLT* (n = 48)

948

(436, 1502)

 NHS SLT vs control* (n = 52)

307

(− 111, 748)

 LSVT vs control* (n = 52)

1345

(825, 1923)

Controlling for duration of illness and baseline VHI, EQ-5D-3L, and PDQ-39 communication scores

 LSVT vs NHS SLT* (n = 44)

1105

(587, 1678)

 NHS SLT vs control* (n = 47)

74

(− 341, 513)

 LSVT vs control* (n = 47)

1175

(626, 1775)

  1. * denotes reference group